Medicenna Therapeutics Corp. (TSX:MDNA)
0.4500
-0.0050 (-1.10%)
May 25, 2026, 3:59 PM EST
Medicenna Therapeutics Employees
Medicenna Therapeutics had 18 employees as of March 31, 2025. The number of employees increased by 2 or 12.50% compared to the previous year.
Employees
18
Change (1Y)
2
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-721.56K CAD
Market Cap
37.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 18 | 2 | 12.50% |
| Mar 31, 2024 | 16 | 0 | - |
| Mar 31, 2023 | 16 | -2 | -11.11% |
| Mar 31, 2022 | 18 | 5 | 38.46% |
| Mar 31, 2021 | 13 | 6 | 85.71% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Medicenna Therapeutics News
- 3 days ago - Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet - GlobeNewsWire
- 12 days ago - Medicenna Announces the Launch of a Marketed Public Offering of Securities - GlobeNewsWire
- 13 days ago - Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma - GlobeNewsWire
- 25 days ago - Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 - GlobeNewsWire
- 4 weeks ago - Medicenna Therapeutics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts
- 4 weeks ago - Medicenna Therapeutics presents new preclinical data from MDNA113 - TheFly
- 5 weeks ago - Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 2 months ago - Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026 - GlobeNewsWire